At Ultragenyx, we’re going beyond every day to transform the lives of people living with rare diseases and lead the future of rare disease medicine. We built our team and our company from the ground up to pioneer new medicines and approaches to drug development for rare and ultrarare diseases and overcome the challenges inherent to treating small patient populations and previously untreated conditions. In 12 years, we’ve achieved four approved therapies in five indications, with a robust pipeline of late-stage therapeutic candidates for debilitating conditions. Our approach to development is informed by patient experience and insights, and we share our science and expertise to help move the entire field forward.
“Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.”
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President
A pledge to being a community where the people we work with, those we serve, and beyond, feel included, celebrated, and empowered.
At Ultragenyx, our commitment to diversity, equity, inclusion, and belonging (DEIB) is brought to life through our strategic pillars.
First, we focus on 'Our People & Our Communities' by building a safe and inclusive culture that welcomes everyone.
Next, in our effort to 'Hire, Develop & Advance Diverse Talent,' we are dedicated to expanding the diversity within our organization, recognizing the strength that comes from a wide range of perspectives and experiences.
Our 'Inclusive Leadership' pillar compels us to be models and champions of DEIB in every aspect of our work, ensuring that these values are reflected in our decision-making and interactions.
Lastly, 'Accountability & Responsibility' emphasizes our drive to monitor, report on, and advance our DEIB initiatives, ensuring that progress is not only made but also communicated effectively.
Through these pillars, Ultragenyx is steadfast in its pursuit of a truly inclusive and empowering community.
Benefits that match our passion
We provide robust benefits to our team members who go above and beyond for those living with rare and ultrarare diseases. All regular, full-time team members are covered starting on the first day of employment.
Our offerings are as unique as our people
Weekly company-sponsored lunches and food trucks
Team building
Personal development workshops
Milestone celebrations
Volunteer events
and much more…
An inclusive culture of value and respect
Ultragenyx brings novel products to those living with rare and ultrarare diseases with a focus on debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of approved therapies and products aimed at diseases with a high unmet medical need for which many have no approved therapies. It takes courage, talent, and dedication to make a meaningful impact for those living with rare diseases.
We are dedicated to fostering an inclusive workplace environment that keeps our teams inspired, empowered, and free to share new ideas—and to better finding solutions that advance the treatment of those living with rare diseases. We put our people first so we can put the rare disease community first.
Jay Courant